Lv4
521 积分 2021-06-12 加入
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody
26天前
已完结
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
27天前
已完结
Atopic dermatitis
1个月前
已完结
Maladaptive immunity to the microbiota promotes neuronal hyperinnervation and itch via IL-17A
1个月前
已完结
Atopic dermatitis
1个月前
已完结
The tissue-specific regulation of immunobiology by IL-17 signaling
1个月前
已完结
Thymus and activation-regulated chemokine (CCL17) as a clinical biomarker in atopic dermatitis: significance and limitations in the new treatment era
1个月前
已完结
Immunoassay-based biomarkers in atopic dermatitis
1个月前
已完结
Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety
1个月前
已完结
B15-09 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT002, a Novel Bispecific IL-4Rα/IL-5 Antibody: Results From the Single- and Multiple-ascending Dose Healthy Volunteers Portions of a Phase I Study
1个月前
已完结
皖公网安备34019202002308
